Survey: Lack of device connectivity leads to medical errors and $30B+ annual cost
17 March 2015
The transcription of medical data from devices by nurses is a common source of medical errors that costs the U.S. healthcare system upward of $30 billion. That's according to a survey and other data assembled by a nonprofit medical research organization, the West Health Institute.
From Ancestry to Health to Drug Development
17 March 2015
Consumer genetics firm 23andMe is getting in on the drug development business with the help of former Genentech executive Richard Scheller, as GenomeWeb has reported.
The Five Essential Truths about Prescription Drug Spending
17 March 2015
Every day patients around the world are living healthier, more productive lives thanks to innovative medicines developed by biopharmaceutical companies. Retail prescription medicines have consistently accounted for just 10 percent of United States health care spending and federal actuaries project this share will remain stable through the next decade.
Biotech in China is built brick-by-brick, but more money would help, BeiGene's Oyler says
17 March 2015
Chemistry and now world-class biology are joining hands in China in ways that will have a profound impact on biotechnology startups and established companies. But it is still early days for many and more money from venture capitalists or other funding sources is welcome, said John Oyler, co-founder and CEO of BeiGene and holder of the same title at his previous venture, BioDuro, which was sold to PPD.
17 March 2015
Scientists have identified a new class of drugs that in animal models dramatically slows the aging process by alleviating symptoms of frailty , improving cardiac function and extending a healthy lifespan.
16 March 2015
Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced the efficacy and safety results from Clearside’s recently completed six-month Phase 1/2 clinical trial.
Physicians Deserve Timely Authoritative Risk Information For Medicines
16 March 2015
A Washington Post article today inaccurately describes the Food and Drug Administration’s (FDA) proposed guidance on distributing peer-reviewed scientific and medical information to healthcare professionals.
China drug approval backlog jumped by a third last year
16 March 2015
China had more than 18,500 drugs waiting for approval at the end of 2014, up by a third from a year before, the official Center for Drug Evaluation said on Friday, reflecting industry concern that it is getting harder to get medicines approved in the China market.
New market for liver disease spawns race for better testing
16 March 2015
As drugmakers develop new medicines to battle a liver disease epidemic, they have created an urgent need for better diagnostics to select patients for treatment and assess their drugs' effectiveness.
GAO report blames DEA for many drug shortages
16 March 2015
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024